...BioPharmaceutical Inc. acquired; and Nardi was VP of worldwide manufacturing at Iradimed Corp.Plasma-derived therapeutics company Kedrion S.p.A. hired...
...& Johnson Janssen Pharmaceuticals ​ Innovent Biologics Inc. eFFECTOR Therapeutics Inc. Nautilus Biotechnology Inc. Epirium Bio Inc. Medeor Therapeutics Inc. BeyondSpring Inc. MaxCyte Inc. Kedrion S.p.A. Kahr...

...sublingual tablet Moderate to severe acute pain PDUFA date 11/3/18 ADMA Biologics Inc. (NASDAQ:ADMA) / Kedrion S.p.A....

...adults who are candidates for systemic therapy or phototherapy Kamada Ltd. (Tel Aviv:KMDA; NASDAQ:KMDA) / Kedrion S.p.A....

...course of rabies vaccine. Kamada said Kedrab will launch in the U.S. early next year. Kedrion S.p.A....
...commercialize Kedrab in the U.S. Kamada markets the product as KamRab outside of the U.S. Kedrion...
...details, and Kamada did not respond to inquiries. Kamada Ltd. (Tel Aviv:KMDA; NASDAQ:KMDA), Rehovot, Israel Kedrion S.p.A....

...course of rabies vaccine. Kamada said Kedrab will launch in the U.S. early next year. Kedrion S.p.A....
...commercialize Kedrab in the U.S. Kamada markets the product as KamRab outside of the U.S. Kedrion...
...inquiries. On Friday, Kamada gained $0.25 to $4.55 on NASDAQ. Jaime De Leon human anti-rabies IgG therapy KamRAB KedRAB Kamada Ltd. Kedrion S.p.A....

...linaclotide Chronic idiopathic constipation (CIC) PDUFA date Early 2017 Kamada Ltd. (Tel Aviv:KMDA; NASDAQ:KMDA) / Kedrion...

...IgG therapy as post-exposure treatment of rabies infection. The PDUFA date is Aug. 29, 2017. Kedrion...
...Ness Ziona, Israel Product: Human anti-rabies IgG therapy (KamRAB) Business: Infectious Alex Himes human anti-rabies IgG therapy KamRAB Kamada Ltd. Kedrion...

...therapy as post-exposure treatment of rabies infection. The company expects an FDA response in mid-2017. Kedrion...

...Myotonic dystrophy type 1 (DM1) Ph I/II data December Kamada Ltd. (Tel Aviv:KMDA; NASDAQ:KMDA) / Kedrion...